Literature DB >> 21228242

Superparamagnetic nanoparticle capture of prions for amplification.

Michael B Miller1, Surachai Supattapone.   

Abstract

Prion diseases are associated with the presence of PrP(Sc), a disease-associated misfolded conformer of the prion protein. We report that superparamagnetic nanoparticles bind PrP(Sc) molecules efficiently and specifically, permitting magnetic separation of prions from a sample mixture. Captured PrP(Sc) molecules retain the activity to seed protein misfolding cyclic amplification (PMCA) reactions, enabling the rapid concentration of dilute prions to improve detection. Furthermore, superparamagnetic nanoparticles clear contaminated solutions of PrP(Sc). Our findings suggest that coupling magnetic nanoparticle capture with PMCA could accelerate and improve prion detection. Magnetic nanoparticles may also be useful for developing a nontoxic prion decontamination method for biologically derived products.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228242      PMCID: PMC3067916          DOI: 10.1128/JVI.02451-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  A prion protein epitope selective for the pathologically misfolded conformation.

Authors:  Eustache Paramithiotis; Marc Pinard; Trebor Lawton; Sylvie LaBoissiere; Valerie L Leathers; Wen-Quan Zou; Lisa A Estey; Julie Lamontagne; Marty T Lehto; Leslie H Kondejewski; Gregory P Francoeur; Maria Papadopoulos; Ashkan Haghighat; Stephen J Spatz; Mark Head; Robert Will; James Ironside; Katherine O'Rourke; Quentin Tonelli; Harry C Ledebur; Avi Chakrabartty; Neil R Cashman
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

2.  Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.

Authors:  Luisa Gregori; Nancy McCombie; Douglas Palmer; Paul Birch; Samuel O Sowemimo-Coker; Antonio Giulivi; Robert G Rohwer
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

3.  Eight prion strains have PrP(Sc) molecules with different conformations.

Authors:  J Safar; H Wille; V Itri; D Groth; H Serban; M Torchia; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

4.  The cellular prion protein binds copper in vivo.

Authors:  D R Brown; K Qin; J W Herms; A Madlung; J Manson; R Strome; P E Fraser; T Kruck; A von Bohlen; W Schulz-Schaeffer; A Giese; D Westaway; H Kretzschmar
Journal:  Nature       Date:  1997 Dec 18-25       Impact factor: 49.962

5.  Infectivity of scrapie prions bound to a stainless steel surface.

Authors:  E Zobeley; E Flechsig; A Cozzio; M Enari; C Weissmann
Journal:  Mol Med       Date:  1999-04       Impact factor: 6.354

6.  Biochemical and immunohistochemical characterization of feline spongiform encephalopathy in a German captive cheetah.

Authors:  Martin Eiden; Christine Hoffmann; Anne Balkema-Buschmann; Matthias Müller; Katrin Baumgartner; Martin H Groschup
Journal:  J Gen Virol       Date:  2010-07-21       Impact factor: 3.891

7.  Novel methods for disinfection of prion-contaminated medical devices.

Authors:  Guillaume Fichet; Emmanuel Comoy; Christelle Duval; Kathleen Antloga; Capucine Dehen; Aurore Charbonnier; Gerald McDonnell; Paul Brown; Corinne Ida Lasmézas; Jean-Philippe Deslys
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

Review 8.  Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier.

Authors:  M Bruce; A Chree; I McConnell; J Foster; G Pearson; H Fraser
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1994-03-29       Impact factor: 6.237

9.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.

Authors:  Alexander H Peden; Mark W Head; Diane L Ritchie; Jeanne E Bell; James W Ironside
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

Review 10.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  7 in total

1.  Enhanced prion detection in biological samples by magnetic particle extraction and real-time quaking-induced conversion.

Authors:  Nathaniel D Denkers; Davin M Henderson; Candace K Mathiason; Edward A Hoover
Journal:  J Gen Virol       Date:  2016-05-27       Impact factor: 3.891

Review 2.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 3.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

4.  Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains.

Authors:  Ajay Singh; Liuting Qing; Qingzhong Kong; Neena Singh
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

5.  Prion disease blood test using immunoprecipitation and improved quaking-induced conversion.

Authors:  Christina D Orrú; Jason M Wilham; Lynne D Raymond; Franziska Kuhn; Björn Schroeder; Alex J Raeber; Byron Caughey
Journal:  MBio       Date:  2011-05-10       Impact factor: 7.867

6.  Enhanced detection of prion infectivity from blood by preanalytical enrichment with peptoid-conjugated beads.

Authors:  Simone Hornemann; Petra Schwarz; Elisabeth J Rushing; Michael D Connolly; Ronald N Zuckermann; Alice Y Yam; Adriano Aguzzi
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

7.  Early detection of chronic wasting disease prions in urine of pre-symptomatic deer by real-time quaking-induced conversion assay.

Authors:  Theodore R John; Hermann M Schätzl; Sabine Gilch
Journal:  Prion       Date:  2013 May-Jun       Impact factor: 3.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.